InvestorsHub Logo
Followers 48
Posts 2095
Boards Moderated 0
Alias Born 02/08/2011

Re: DataStream post# 17124

Wednesday, 07/16/2014 4:48:56 PM

Wednesday, July 16, 2014 4:48:56 PM

Post# of 46204
My understanding of WDDD and WORX.

Most of my understanding is from the companies own SEC reports. WDDD shows zero revenue for Q1 2014, but I am willing to overlook that because of the patent case that is going on and the value I expect from it eventually. I own shares in WDDD on the basis of what I expect is the present value of the patents and the October 2014 Markman hearing.

WORX shows $222 in Q1 2014 revenue. While it does have a license to use the online patents from WDDD, with WDDD approval, it looks like they are not able to do anything meaningful with them.

I have no objections to WORX being sold off as a shell for some other company looking for a low cost way to get access to public markets, but I think the hype surrounding the new joint venture/probably future reverse merger is not warranted since the LLC does not seem to have any operations. I would prefer a company that has ongoing operations (and is profitable) to be doing a reverse merger into WORX. That I would feel good about.

While I am a libertarian on drug policy, I do not feel good about, in effect, being a part owner in a company that will be pushing such use, plus I do not see enough demand for such a product/service to justify the valuations that people are looking at (or fear will come if WORX starts to get pumped).

Louis J. Desy Jr
LouisDesyjr@gmail.com

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent WDDD News